Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Raw Health In Violation Of FTC Order, Could Face Monetary Penalties – DoJ

This article was originally published in The Tan Sheet

Executive Summary

North Carolina-based dietary supplement marketer Raw Health has continued to make unsubstantiated marketing claims in violation of a 2002 Federal Trade Commission order, resulting in a civil complaint by the Department of Justice, FTC announced Sept. 2

You may also be interested in...

Colloidal Silver Antibiotic Superiority Claims Barred Under FTC Settlement

A Web site operator has been barred from representing colloidal silver as "superior to antibiotics in killing disease-causing organisms" or treating burns absent reliable scientific evidence, according to a Federal Trade Commission consent order

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts